Holen Sie sich die Stockscreener-App
5.58
1.10%
0.13
Schlusskurs vom Vortag:
$5.45
Offen:
$5.41
24-Stunden-Volumen:
210.73K
Relative Volume:
0.32
Marktkapitalisierung:
$381.61M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-96.66M
KGV:
-2.5953
EPS:
-2.15
Netto-Cashflow:
$-83.73M
1W Leistung:
+4.75%
1M Leistung:
+20.04%
6M Leistung:
+10.42%
1J Leistung:
-55.56%
1-Tages-Spanne:
$5.345
$5.73
1-Wochen-Bereich:
$5.29
$5.78
52-Wochen-Spanne:
$2.86
$13.93
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Firmenname
Olema Pharmaceuticals Inc
Sektor
Branche
Telefon
(415) 651-3316
Adresse
780 BRANNAN STREET, SAN FRANCISCO
Vergleichen Sie OLMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
5.56 | 395.33M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.64 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
600.07 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.97 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
662.78 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
312.09 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Bestätigt | Citigroup | Buy |
| 2024-04-02 | Eingeleitet | Goldman | Buy |
| 2024-01-30 | Eingeleitet | Citigroup | Buy |
| 2023-07-21 | Eingeleitet | Oppenheimer | Outperform |
| 2023-05-05 | Eingeleitet | CapitalOne | Overweight |
| 2023-02-22 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-06 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-06-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-12-07 | Fortgesetzt | Cowen | Outperform |
| 2020-12-14 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-12-14 | Eingeleitet | Cowen | Outperform |
| 2020-12-14 | Eingeleitet | JP Morgan | Overweight |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Olema Pharmaceuticals Inc Aktie (OLMA) Neueste Nachrichten
Published on: 2025-08-20 21:48:05 - Newser
Olema Oncology to Participate in Upcoming Investor Conferences - GlobeNewswire
Breast Cancer Drug Developer Olema Oncology Set for 5 Major Healthcare Conference Appearances in September - Stock Titan
Published on: 2025-08-20 14:18:04 - Newser
Is Olema Pharmaceuticals Inc. in Accumulation Phase Now2025 Technical Overview & Expert Approved Momentum Trade Ideas - newsyoung.net
Applying sector rotation models to Olema Pharmaceuticals Inc.Price Action & Stepwise Entry/Exit Trade Alerts - Newser
JPMorgan Chase & Co. Increases Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $29.00 - MarketBeat
What’s next for Olema Pharmaceuticals Inc. stock priceBond Market & Entry Point Confirmation Signals - Newser
Order flow analysis tools used on Olema Pharmaceuticals Inc.Market Growth Summary & AI Driven Stock Movement Reports - Newser
Measuring Olema Pharmaceuticals Inc.’s beta against major indicesCPI Data & Proven Capital Preservation Methods - Newser
Is Olema Pharmaceuticals Inc. stock poised for growthIndex Update & Risk Controlled Daily Trade Plans - Newser
What institutional flow reveals about Olema Pharmaceuticals Inc.July 2025 Levels & Weekly High Momentum Picks - Newser
Analysts Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Target Price at $24.00 - MarketBeat
How high can Olema Pharmaceuticals Inc. stock goJuly 2025 Spike Watch & Growth Focused Stock Reports - Newser
Is it too late to sell Olema Pharmaceuticals Inc.Weekly Stock Report & Fast Moving Trade Plans - Newser
Applying big data sentiment scoring on Olema Pharmaceuticals Inc.Portfolio Value Summary & Low Volatility Stock Suggestions - Newser
What recovery options are there for Olema Pharmaceuticals Inc.July 2025 Rallies & Daily Price Action Insights - Newser
What high frequency data says about Olema Pharmaceuticals Inc.2025 Market WrapUp & Expert Approved Trade Ideas - Newser
Published on: 2025-08-19 03:58:55 - newsyoung.net
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives $24.00 Average PT from Analysts - Defense World
Combining price and volume data for Olema Pharmaceuticals Inc.Trade Ideas & Low Risk Investment Opportunities - Newser
Does Olema Pharmaceuticals Inc. qualify in momentum factor screeningInflation Watch & Expert Approved Trade Ideas - Newser
Momentum divergence signals in Olema Pharmaceuticals Inc. chartJuly 2025 Final Week & Real-Time Volume Spike Alerts - Newser
Key metrics from Olema Pharmaceuticals Inc.’s quarterly dataJobs Report & Weekly High Potential Stock Alerts - Newser
Olema Pharmaceuticals (NASDAQ:OLMA) Given New $21.00 Price Target at Citigroup - MarketBeat
Is a relief rally coming for Olema Pharmaceuticals Inc. holders2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - Newser
What moving averages say about Olema Pharmaceuticals Inc.2025 Buyback Activity & Stepwise Entry and Exit Trade Signals - Newser
Identifying reversal signals in Olema Pharmaceuticals Inc.Quarterly Earnings Report & Consistent Profit Trading Strategies - Newser
Volatility clustering patterns for Olema Pharmaceuticals Inc.2025 EndofYear Setup & Safe Capital Investment Plans - Newser
Olema Pharmaceuticals (NASDAQ:OLMA) Issues Quarterly Earnings Results, Misses Expectations By $0.08 EPS - MarketBeat
Finanzdaten der Olema Pharmaceuticals Inc-Aktie (OLMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Olema Pharmaceuticals Inc-Aktie (OLMA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Graham G. Walmsley | Director |
Dec 17 '24 |
Sale |
6.75 |
700,761 |
4,730,137 |
0 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER |
Dec 16 '24 |
Option Exercise |
4.87 |
14,000 |
68,180 |
129,509 |
0.91%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):